Anebulo Pharmaceuticals, Inc. (ANEB) Executive Compensation
Anebulo Pharmaceuticals, Inc. (ANEB) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ANEB
CIK: 1815974
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 06/30
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
EisnerAmper LLP
Auditor SinceSince 6/30/2020 12:00:00 AM
Lead Engagement PartnerMichele Epstein
Audit LocationIselin, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 15-12G | 2026-03-02 | — | 15-12G | 0001493152-26-008559 | View SEC Doc Filr Page |
| 25 | 2026-02-17 | — | 25 | 0001493152-26-007168 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-13 | — | SCHEDULE 13G/A Filing | 0001104659-26-015319 | View SEC Doc Filr Page |
| 10-Q | 2026-02-12 | 2025-12-31 | 10-Q | 0001493152-26-006446 | View SEC Doc Filr Page |
| 8-K | 2026-02-12 | 2026-02-12 | 8-K | 0001493152-26-006428 | View SEC Doc Filr Page |
| 8-K | 2026-02-06 | 2026-02-05 | 8-K | 0001493152-26-005463 | View SEC Doc Filr Page |
| SC 13E3/A | 2026-01-29 | — | SC TO-I/A | 0001493152-26-004156 | View SEC Doc Filr Page |
| 8-K | 2026-01-29 | 2026-01-29 | 8-K | 0001493152-26-004154 | View SEC Doc Filr Page |
| SC 13E3/A | 2026-01-27 | — | SC TO-I/A | 0001493152-26-003720 | View SEC Doc Filr Page |
| 8-K | 2026-01-27 | 2026-01-26 | 8-K | 0001493152-26-003718 | View SEC Doc Filr Page |
| CORRESP | 2026-01-08 | — | CORRESP Filing | 0001493152-26-000916 | View SEC Doc Filr Page |
| SC 13E3/A | 2026-01-08 | — | SC TO-I/A | 0001493152-26-000914 | View SEC Doc Filr Page |
| UPLOAD | 2025-12-31 | — | UPLOAD Filing | 0000000000-25-011921 | View SEC Doc Filr Page |
| SC 13E3 | 2025-12-22 | — | SC TO-I | 0001493152-25-028828 | View SEC Doc Filr Page |
| SC TO-I | 2025-12-22 | — | SC TO-I | 0001493152-25-028680 | View SEC Doc Filr Page |
| 8-K | 2025-12-22 | 2025-12-22 | 8-K | 0001493152-25-028676 | View SEC Doc Filr Page |
| 10-Q | 2025-11-13 | 2025-09-30 | 10-Q | 0001493152-25-022350 | View SEC Doc Filr Page |
| 8-K | 2025-11-13 | 2025-11-13 | 8-K | 0001493152-25-022310 | View SEC Doc Filr Page |
| SC 13E3/A | 2025-10-14 | — | SC 13E3/A | 0001493152-25-017826 | View SEC Doc Filr Page |
| CORRESP | 2025-10-10 | — | CORRESP Filing | 0001493152-25-017823 | View SEC Doc Filr Page |
| PRER14A | 2025-10-10 | — | PRER14A | 0001493152-25-017820 | View SEC Doc Filr Page |
| 10-K | 2025-09-29 | 2025-06-30 | 10-K | 0001493152-25-016015 | View SEC Doc Filr Page |
| 8-K | 2025-09-29 | 2025-09-29 | 8-K | 0001493152-25-016001 | View SEC Doc Filr Page |
| S-8 POS | 2025-09-26 | — | S-8 POS | 0001493152-25-015078 | View SEC Doc Filr Page |
| S-8 POS | 2025-09-26 | — | S-8 POS | 0001493152-25-015075 | View SEC Doc Filr Page |